SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
爱我嫉妒我
Lv1
40 积分
2022-07-31 加入
最近求助
最近应助
互助留言
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
13天前
已完结
Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials
22天前
已完结
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
1个月前
已完结
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
1个月前
已完结
Overlap Weighting
1个月前
已完结
Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial
1个月前
已完结
How Useful Are International Treatment Guidelines in Low- and Middle-Income Countries?
2个月前
已完结
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource–Stratified Guideline Q and A
2个月前
已完结
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
2个月前
已完结
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
2个月前
已完结
没有进行任何应助
感谢
1个月前
已找到文献【积分已退回】
2个月前
需要附件
11个月前
SABCS的材料
11个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论